Article

marketwatch.com on 2021-05-04 08:25

AstraZeneca's Farxiga gets U.S. FDA approval

AstraZeneca PLC said Tuesday that the U.S. Food and Drug Administration approved Farxiga for the treatment of chronic kidney disease in patients at ...

Related news